Data / Form D filings / Andson Biotech Inc.
Andson Biotech Inc.: Form D filings
Andson Biotech Inc., a biotechnology company in Atlanta, GA, filed 2 Form D notices with the SEC between 2024 and 2025. The latest, on October 22, 2025, reports $4.7 million sold of a $5 million offering to 29 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1705 COMMERCE DR NW, SUITE 100, Atlanta, GA, 30318
- Phone
- (727) 389-7725
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2021
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2017131
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 22, 2025 | New notice | $5,000,000 | $4,735,000 | $265,000 | 29 | Oct 17, 2025 | sec.gov |
| Mar 26, 2024 | New notice | $3,600,000 | $3,600,000 | 37 | Mar 12, 2024 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Andrei Fedorov | Director | |
| Mason Chilmonczyk | Executive Officer, Director | |
| Jim Filippini | Executive Officer | |
| Thomas O'Brien | Director | |
| Glenn Epstein | Director | |
| James Ross | Director |
Other biotechnology companies in Georgia that filed recently
- Opus Medical Therapies, LLC $485,089 · Sep 22, 2026
- Airway Therapeutics, Inc. $43.5 million · Sep 9, 2026
- FEMASYS INC $30 million · Aug 20, 2026
Every Form D from the week of Oct 20, 2025 · All recent filings in Georgia · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Andson Biotech Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.